<i>RAS</i> Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF InhibitorsPatrick A. Oberholzer, Levi A. Garraway|Journal of Clinical Oncology|2011Cited by 381